UNIVERSITY OF MELBOURNE
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Private
- Established
- 1853-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.unimelb.edu.au
Human Infection Study of H3N2 Influenza in Healthy Adults
Not Applicable
Recruiting
- Conditions
- Influenza
- First Posted Date
- 2025-05-15
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 12
- Registration Number
- NCT06972810
- Locations
- 🇦🇺
Doherty Clinical Trials, Melbourne, Victoria, Australia
Caffeine Citrate to Improve Neonatal Outcomes.
- First Posted Date
- 2025-05-15
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 3900
- Registration Number
- NCT06972849
A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19
Phase 1
Not yet recruiting
- Conditions
- COVID-19 Infection
- Interventions
- Drug: PDI204Other: 0.9 % saline
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 32
- Registration Number
- NCT06965751
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
Cross Bracing Protocol Versus Surgery for Acute Anterior Cruciate Ligament Rupture
Not Applicable
Not yet recruiting
- Conditions
- Anterior Cruciate Ligament Rupture
- First Posted Date
- 2025-05-04
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 180
- Registration Number
- NCT06956339
- Locations
- 🇦🇺
The University of Melbourne, Melbourne, Victoria, Australia
Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How?
Not Applicable
Not yet recruiting
- Conditions
- Irritable Bowel Syndrome (IBS)Intestinal DiseasesGastrointestinal Disease
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 200
- Registration Number
- NCT06940596
Preterm Rupture of Membranes Optimising Antibiotics Trial
Not Applicable
Not yet recruiting
- Conditions
- PPROMPreterm
- Interventions
- Drug: Erythromycin 250mg + placeboDrug: Azithromycin 500mg + placeboDrug: Erythromycin 250mg and Amoxicillin 500mg
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 3900
- Registration Number
- NCT06906757
A New Website for Australian IVF Patients: 'Evidence-based IVF'
Not Applicable
Recruiting
- Conditions
- IVFIVF TreatmentIVF-ETIVF/ICSI
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 850
- Registration Number
- NCT06885151
- Locations
- 🇦🇺
MDHS, Melbourne, Victoria, Australia
Experimental Malaria Infection of Healthy Malaria-Naive Adults by Mosquito Bite with the Genetically Modified Plasmodium Falciparum NF54/iGP3 GAP
Phase 1
Not yet recruiting
- Conditions
- Malaria FalciparumMalaria InfectionMalaria Transmission
- Interventions
- Biological: NF54/iGP3
- First Posted Date
- 2025-03-18
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 2
- Registration Number
- NCT06881732
- Locations
- 🇦🇺
Doherty Clinical Trials, Melbourne, Victoria, Australia
Spinal Cord Injury Neurorecovery Collaboration
Not Applicable
Not yet recruiting
- Conditions
- Spinal Cord Injuries
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 24
- Registration Number
- NCT06871254
- Locations
- 🇦🇺
Austin Health, Heidelberg, Victoria, Australia
Prehabilitation for Patients Undergoing Lung Cancer Surgery
Not Applicable
Recruiting
- Conditions
- Lung Cancer (NSCLC)
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 25
- Registration Number
- NCT06716437
- Locations
- 🇦🇺
The University of Melbourne, Department of Physiotherapy, Parkville, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath